Multicenter Phase II trial of high-dose imatinib mesylate in metastatic melanoma: significant toxicity with no clinical efficacy
(Q82976088)
scientific article published on 01 May 2006
scientific article published on 01 May 2006
Language:
Current Data About
Multicenter Phase II trial of high-dose imatinib mesylate in metastatic melanoma: significant toxicity with no clinical efficacy
other details
description | scientific article published on 01 May 2006 |
External Links
(P356) |
10.1002/CNCR.21834
|
(P698) |
16565971
|